Navigation Links
Two-Drug Combo Fights Brain Tumors
Date:10/19/2007

Avastin, irinotecan may hit the cancer at different points, researchers say

FRIDAY, Oct. 19 (HealthDay News) -- A combination of the drug bevacizumab (brand name Avastin) and the standard chemotherapy agent irinotecan may benefit patients with a type of deadly brain tumor called glioblastoma multiforme (GBM), says a Duke University pilot study.

This treatment approach may extend the length of time GBM patients can survive without tumor growth and may improve overall survival, according to researchers at Duke's Preston Robert Tisch Brain Tumor Center.

The study included 35 patients whose GBMs returned after they'd had standard therapy, possibly including surgery, radiation and chemotherapy. After the patients received the combination bevacizumab/irinotecan therapy, almost half had no tumor progression after six months, and 80 percent were still alive six months after diagnosis.

The findings are published in the Oct. 20 issue of the Journal of Clinical Oncology.

"These results represent tremendous hope for these patient and their families," lead investigator Dr. James J. Vredenburgh, a neuro-oncologist, said in a prepared statement.

He noted that 75 percent of patients with recurrent GBM treated with standard therapy, such as chemotherapy alone, have tumor progression at six months, and fewer than 50 percent are alive after six months.

"We speculate that bevacizumab and irinotecan each attack a particular characteristic of the tumor independently, or they work together, with bevacizumab suppressing the growth of blood vessels which makes the tumor more susceptible to the chemotherapy," Vredenburgh said.

"Further studies will tease out the exact mechanism of the therapy's success, and we also hope to study the effectiveness of this treatment in patients with newly diagnosed GBM," he added.

More information

The U.S. National Cancer Institute has more about
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. New Two-Drug Regime To Tackle Malaria
2. Drug Combo Works Better for children with ADHD, Tics
3. Scanning Combo Helps Detect Lung Cancer
4. Relief From Asthma With New Combo Therapy
5. Calcium-Vitamin D Combo For Reduced Fracture Risk
6. Drug Combo Improves Performance Of Multiple Sclerosis Drug
7. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
8. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
9. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
10. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
11. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... Orion, Clarkston, Metamora, Michigan (PRWEB) May 03, 2015 ... She has worked to enhance the well being of the men, ... generalist in a hospital, followed by providing care for families in ... with as an Adult Nurse Practitioner began wondering if I could ... the birth of my own children with my mentor Nurse Midwife, ...
(Date:5/3/2015)... ANGELES, American Telemedicine Association 2015 Meeting & Tradeshow ... e-health solutions, a full-service telemedicine and mobile health ... new platform, VITA health services for chronic disease ... services platform enables remote patient monitoring of a ... heart failure (CHF), diabetes, COPD, hypertension and other ...
(Date:5/3/2015)... 2015 " Bubbly Walrus ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... game. , The best games to play on smartphones are ... users killing brain cells with a video game that just ...
(Date:5/3/2015)... 2015 “ BolehVPN ” was featured on ... the latest and coolest technology products available to consumers. Scott ... the review and shared with viewers how to protect their ... days is on computers and even more so online. It ... people all over the world. In terms of work, the ...
(Date:5/3/2015)... (PRWEB) May 03, 2015 NuevaCare announced ... at two upcoming area seminars. The first event will ... Annual Regional Stroke Conference to be held at The ... on Wednesday, May 13 during the Dementia Conference to ... , “These seminars offer an excellent opportunity to learn ...
Breaking Medicine News(10 mins):Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 3Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2
... found out that a protein called NMNAT can delay the ... level. The researchers from Baylor College of// Medicine in a ... online today said that NMNAT protects against nerve cell degeneration ... the question if a drug might be developed that could ...
... wines that belong to the vineyards of France and Italy are ... effects of fatty meals on the heart can be offset by ... has shown. Wines from these regions contain high levels of a ... have also proved the heart healthy benefits of a daily glass ...
... Center and colleagues at four other medical centers have ... that may contribute to early atherosclerosis. ,“If we ... life who have a genetic predisposition to develop atherosclerosis, ... and stroke sooner and more aggressively,” said David Herrington, ...
... a new drug that might cease men from ejaculation during ... on is that the contraction of the longitudinal muscle in ... out of the penis. ,This method of contraception ... to which researchers claim have chemicals to block male sperms. ...
... unknown immunodeficiency disease was discovered by scientists about twenty-five ... 'AIDS'. //Ever since, 'Acquired Immune Deficiency Syndrome' or AIDS, ... to the latest figures enabled by the UNAIDS/WHO 2006 ... world are grappling with the disease. ,AIDS ...
... Research, the data from Population Based Cancer Registry, Delhi ... specific// incidence rates of breast cancer below 40 years ... National Cancer Control Programme (NCCP), special emphasis is now ... awareness. Grant-in-aid is provided to Non-Governmental Organisations to create ...
Cached Medicine News:Health News:NMNAT Protein Protects Against Nerve Cell Degeneration 2Health News:Study Underway to Identify Genes Contributing to Heart Attack Risk 2Health News:'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS Preventio 2Health News:'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS Preventio 3Health News:'Red'y to Fight HIV – 'AbstinenceBehaviorCondom', Sacrosanct to AIDS Preventio 4
(Date:5/1/2015)... , May 1, 2015  Thoratec Corporation (NASDAQ: THOR ... save, support and restore failing hearts, announced today that ... role of President, International. This new ... operations outside of North America , including ... and Latin America , and reports directly ...
(Date:5/1/2015)...  CytRx Corporation (CYTR), a biopharmaceutical research and ... results for the three months ended March 31, ... and upcoming milestones for its clinical development programs. ... early months of 2015, including the announcement of ... in patients with soft tissue sarcoma, and positive ...
(Date:5/1/2015)... 1, 2015 The Institute for Healthcare Advancement ... award winners. The IHA Health Literacy Awards aim to ... on the practice of educating or empowering organizations to ... awards in three categories: innovative programs, published materials and ... Hero award. In the area of innovative ...
Breaking Medicine Technology:Thoratec Announces Addition To Senior Management Team 2Thoratec Announces Addition To Senior Management Team 3CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11Institute for Healthcare Advancement Announces 2015 Award Winners 2
... International Corporation (NASDAQ: PRXL ) announced today ... Conference in Boston, MA.  Josef von Rickenbach, Chairman and ... PAREXEL at 3:30 p.m. ET on Monday, March 5, 2012. ... presenting at the Raymond James Investors Conference in Orlando, ...
... ReportsnReports adds new market research report , ... and Market Forecasts to 2018 , to its ... $1,412.8m by 2018 growing at a CAGR of 5%. The ... for minimally invasive procedures and technology advances that make surgery ...
Cached Medicine Technology:PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference 2Electrosurgical Devices Market to Grow at a CAGR of 5% Globally From 2011-2018 2Electrosurgical Devices Market to Grow at a CAGR of 5% Globally From 2011-2018 3Electrosurgical Devices Market to Grow at a CAGR of 5% Globally From 2011-2018 4
... proteins produced with recombinant technology, that have been ... capable of detecting the different types of T.cruzi ... with amino acid sequences repeated in tandem. SAPA ... phase of the infection, it reacts with 93% ...
Elisa test for qualitative detection of Total antibodies to Trypanosoma Cruzi in human serum or plasma....
... defibrillator lead features a patented ... flexibility and maneuverability of a ... physician who prefers a lead ... SPL lead also promotes low ...
TVL defibrillation leads have a patented coiled-coil design for faster, easier insertion and more precise intracardiac placement. Designed with an integrated bipolar design, the lead enables high-vol...
Medicine Products: